We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

22 hedge funds and large institutions have $3.34M invested in Capricor Therapeutics in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

15% more capital invested

Capital invested by funds: $2.9M → $3.34M (+$433K)

0% more funds holding

Funds holding: 22 → 22 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$659K
2
GPCM
Granite Point Capital Management
Massachusetts
+$254K
3
FWM
Frontier Wealth Management
Missouri
+$177K
4
Citadel Advisors
Citadel Advisors
Florida
+$106K
5
CBA
Coastal Bridge Advisors
Connecticut
+$18.8K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$73K
2
VKH
Virtu KCG Holdings
New York
-$60K
3
Goldman Sachs
Goldman Sachs
New York
-$17.9K
4
UBS Group
UBS Group
Switzerland
-$12K
5
GC
Globeflex Capital
California
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.18M +$659K +17,536 +96%
CBA
2
Coastal Bridge Advisors
Connecticut
$404K +$18.8K +500 +4%
Goldman Sachs
3
Goldman Sachs
New York
$327K -$17.9K -475 -4%
AA
4
Apriem Advisors
California
$230K – – –
Brown Advisory
5
Brown Advisory
Maryland
$230K – – –
GPCM
6
Granite Point Capital Management
Massachusetts
$219K +$254K +6,750 New
FWM
7
Frontier Wealth Management
Missouri
$152K +$177K +4,700 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$145K – – –
Morgan Stanley
9
Morgan Stanley
New York
$135K -$790 -21 -0.5%
Vanguard Group
10
Vanguard Group
Pennsylvania
$96K +$3.76K +100 +4%
Citadel Advisors
11
Citadel Advisors
Florida
$93K +$106K +2,817 New
BFA
12
BlackRock Fund Advisors
California
$52K +$188 +5 +0.3%
HIIFS
13
Harel Insurance Investments & Financial Services
Israel
$23K – – –
PA
14
Perceptive Advisors
New York
$13K – – –
CFN
15
Cordasco Financial Network
Florida
$12K – – –
Bank of America
16
Bank of America
North Carolina
$8K +$7.22K +192 +362%
FANJ
17
Financial Architects (New Jersey)
New Jersey
$6K – – –
BA
18
BlackRock Advisors
Delaware
$5K – – –
TRCT
19
Tower Research Capital (TRC)
New York
$2K -$752 -20 -26%
BIM
20
BlackRock Investment Management
Delaware
$1K – – –
Walleye Trading
21
Walleye Trading
New York
$1K +$752 +20 New
Millennium Management
22
Millennium Management
New York
– -$73K -1,857 Closed
VKH
23
Virtu KCG Holdings
New York
– -$60K -1,525 Closed
UBS Group
24
UBS Group
Switzerland
– -$12K -300 Closed
GC
25
Globeflex Capital
California
– -$1K -14 Closed

CAPR Hedge Fund Activity: Q3 2016 in Review

22 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q3 2016, worth a combined $3.34M — up 15% from $2.9M a quarter earlier.

Fund positioning in CAPR was balanced in Q3 2016: 4 funds opened new positions, 4 closed out, 5 added to existing stakes and 3 trimmed.

The largest buyer was Sabby Management, adding an estimated $659K. The largest seller was Millennium Management, exiting entirely with an estimated $73K sold.

  • 22 institutional investors held Capricor Therapeutics (CAPR) as of Q3 2016, unchanged from Q2 2016.
  • Funds reported $3.34M of Capricor Therapeutics stock for Q3 2016, up 15% quarter-over-quarter.
  • 4 funds opened new Capricor Therapeutics positions in Q3 2016 and 4 closed out, a net change of 0 holders.
  • The largest Capricor Therapeutics buyer in Q3 2016 was Sabby Management, an estimated $659K added.
  • The largest Capricor Therapeutics seller in Q3 2016 was Millennium Management, an estimated $73K sold.

Based on aggregated 13F filings for Q3 2016.